KCM
RGEN icon

Kennedy Capital Management’s Repligen RGEN Stock Holding History

Kennedy Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,157
Closed -$404K – 639
2022
Q3 		$404K Sell
2,157
-1,105
-34% -$233K 0.01% 561
2022
Q2 		$530K Sell
3,262
-6
-0.2% -$949 0.01% 539
2022
Q1 		$615K Buy
3,268
+883
+37% +$168K 0.01% 544
2021
Q4 		$632K Sell
2,385
-203
-8% -$54.7K 0.01% 548
2021
Q3 		$748K Sell
2,588
-44
-2% -$11.3K 0.02% 549
2021
Q2 		$525K Buy
2,632
+119
+5% +$23.1K 0.01% 574
2021
Q1 		$489K Buy
+2,513
New +$515K 0.01% 603

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Kennedy Capital Management's RGEN Position: Q4 2022 in Review

Kennedy Capital Management sold out of Repligen (RGEN) in Q4 2022, closing a stake of 2,157 shares — an estimated $404K sold.

Kennedy Capital Management first reported a position in RGEN in Q1 2021 and held it in 7 quarters. The position peaked at $748K in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • Kennedy Capital Management reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • Kennedy Capital Management sold 2,157 Repligen shares in Q4 2022, an estimated $404K.
  • Kennedy Capital Management first reported a position in Repligen in Q1 2021 and held it in 7 quarters.
  • Kennedy Capital Management's Repligen position peaked at $748K in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Kennedy Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.